We are live on ! Find out more
FNCH

Finch Therapeutics Group, Inc. Common Stock
FNCH

Delisted

FNCH was delisted on the 24th of May, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Finch Therapeutics Group, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $29.1K → $0 (-$29.1K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
–
Holders Change
-1
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
LSAG
Lake Street Advisors Group
New Hampshire
-$29.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
LSAG
1
Lake Street Advisors Group
New Hampshire
– -$29.1K -21,206 Closed

FNCH Hedge Fund Activity: Q3 2024 in Review

0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Finch Therapeutics Group, Inc. Common Stock (FNCH) for Q3 2024, worth a combined $0 — down 100% from $29.1K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of FNCH and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Lake Street Advisors Group, exiting entirely with an estimated $29.1K sold.

  • 0 institutional investors held Finch Therapeutics Group, Inc. Common Stock (FNCH) as of Q3 2024, down from 1 in Q2 2024.
  • Funds reported $0 of Finch Therapeutics Group, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Finch Therapeutics Group, Inc. Common Stock positions in Q3 2024 and 1 closed out, a net change of -1 holder.
  • The largest Finch Therapeutics Group, Inc. Common Stock seller in Q3 2024 was Lake Street Advisors Group, an estimated $29.1K sold.

Based on aggregated 13F filings for Q3 2024.